Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-066385)

Filing Details

Accession Number:: 0001209191-14-066385
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-04 18:35:35
Reporting Period:: 2014-11-03

Filing Date:: 2014-11-04
Accepted Time:: 2014-11-04 18:35:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1620668	Stephen Garbacz	C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2014-11-03	868	$2.19	13,941	No	4	M	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2014-11-03	868	$26.44	13,073	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-11-03	868	$0.00	868	$2.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,702		2022-10-02	No	4	M	Direct

Footnotes

The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This option was granted on October 3, 2012 with respect to 41,666 shares of Common Stock, with 25% vesting on October 3, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.